Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs
β Scribed by Walter Smalley; C. Michael Stein; Patrick G. Arbogast; Glenn Eisen; Wayne A. Ray; Marie Griffin
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 61 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.
## Abstract Clinical, laboratory, genetic, and radiologic studies were evaluated for 18 patients with rheumatoid arthritis who were treated for a mean of 16.6 months with a regimen involving supplementary aspirin and piroxicam, an investigational, nonsteroidal antiinflammatory agent. Although impro